(r)-3-hydroxybutanoic acid

(r)-3-hydroxybutanoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2725 references associated with (r)-3-hydroxybutanoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for (r)-3-hydroxybutanoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (r)-3-hydroxybutanoic acid

MeSH term MeSH ID Detail
Multiple Endocrine Neoplasia Type 1 D018761 2 associated lipids
HIV Wasting Syndrome D019247 3 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Basal Ganglia Cerebrovascular Disease D020144 1 associated lipids
Epilepsy, Reflex D020195 5 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Heredodegenerative Disorders, Nervous System D020271 1 associated lipids
Intracranial Hemorrhages D020300 2 associated lipids
Median Neuropathy D020423 1 associated lipids
Ulnar Neuropathies D020424 1 associated lipids
Per page 10 20 50 100 | Total 185

PubChem Associated disorders and diseases

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with (r)-3-hydroxybutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 2707
Authors Title Published Journal PubMed Link
Combs DJ et al. Glycolytic inhibition by 2-deoxyglucose reduces hyperglycemia-associated mortality and morbidity in the ischemic rat. 1986 Sep-Oct Stroke pmid:3764973
Lundy EF et al. Elevated blood ketone and glucagon levels cannot account for 1,3-butanediol induced cerebral protection in the Levine rat. 1987 Jan-Feb Stroke pmid:3810756
Rising CL and D'Alecy LG Hypoxia-induced increases in hypoxic tolerance augmented by beta-hydroxybutyrate in mice. 1989 Stroke pmid:2772983
Lundy EF et al. Butanediol induced cerebral protection from ischemic-hypoxia in the instrumented Levine rat. 1984 May-Jun Stroke pmid:6729886
Gueldry S et al. Beneficial effect of 1,3-butanediol on cerebral energy metabolism and edema following brain embolization in rats. 1990 Stroke pmid:2219211
Schreiber RA and Ungar AL Temporal changes in liver, blood, and brain glucose, glycogen, and beta-hydroxybutyrate after ethanol in C57BL/6J mice. 1984 Subst Alcohol Actions Misuse pmid:6533840
Hamanoue M et al. A correlation between arterial ketone body ratio and concentration of beta-hydroxybutyrate as an indicator of hepatic functional reserve. 1992 Surg. Today pmid:1392328
Mizobata Y et al. Oxidation of D(-)3-hydroxybutyrate administered to rats with extensive burns. 1996 Surg. Today pmid:8845609
Heindorff H et al. Hormonal and neural blockade prevents the postoperative increase in amino acid clearance and urea synthesis. 1992 Surgery pmid:1350868
Koustova E et al. Ketone and pyruvate Ringer's solutions decrease pulmonary apoptosis in a rat model of severe hemorrhagic shock and resuscitation. 2003 Surgery pmid:12947328